Cargando…
R0 Liver Resection should be a First-line Treatment for Selected Patients with Intermediate Hepatocellular Cancer
Autores principales: | Janicko, Martin, Drazilova, Sylvia, Jarcuska, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318282/ https://www.ncbi.nlm.nih.gov/pubmed/37408800 http://dx.doi.org/10.14218/JCTH.2022.00123 |
Ejemplares similares
-
Defining the Value of Extracorporeal Liver Support in Acute and Acute-on-chronic Liver Failure
por: van Hoek, Bart
Publicado: (2023) -
Therapeutic Use of Viruses: Newcastle Disease Virus HK84 Oncolytic Treatment for Hepatocellular Carcinoma
por: Baiocchi, Leonardo, et al.
Publicado: (2022) -
COVID-19 and Liver Transplantation: Challenges and Opportunities
por: Tsoulfas, Georgios
Publicado: (2023) -
SGLT-2 Inhibitor and GLP-1 Receptor Agonist Treatment for Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Is Their Combination the Optimal Treatment Option?
por: Patoulias, Dimitrios, et al.
Publicado: (2022) -
Some highlights of research on aging with invertebrates, 2010
por: Partridge, Linda
Publicado: (2011)